Inventor · disambiguated record
Xiaoling Jiang
Also filed as: JIANG XIAOLING
1 granted patent·13 pending applications·10 citations·filing 2018–2023
34Inventor score
Files withSHENGHE CHINA BIOPHARMACEUTICAL CO LTD11JIANG XIAOLING1SHENGHE CHINA BIOPHARMACEUTICAL CO1SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD1
Top patents by PatentIndex Score
14 records- 0150US2023303562A1Pyrazole compound and preparation method therefor and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 0250US2024218065A1Multispecific antigen-binding protein and use thereofSHENGHE CHINA BIOPHARMACEUTICAL CO·Filed 2022·Application pending·0 cites
- 0350US2025243287A1Anti-ccr8 antibody or antigen-binding fragment thereofSHENGHE CHINA BIOPHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0449US2025092140A1Bispecific antibody binding to b7h3 and nkp30, and application thereofSHENGHE CHINA BIOPHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0548US2024392007A1Heterodimeric protein and application thereofSHENGHE CHINA BIOPHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0647USD939088SMole remover penJIANG XIAOLING·Filed 2018·Granted Dec 21, 2021·10 cites·1 claims
- 0747US2024327543A1Multispecific antigen-binding protein and use thereofSHENGHE CHINA BIOPHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0847US2024336682A1Multispecific antigen-binding protein and use thereofSHENGHE CHINA BIOPHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0946US2025250335A1Antibody against ceacam5 and ceacam6, and use thereofSHENGHE CHINA BIOPHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1045US2025320309A1Bispecific antigen binding proteinSHENGHE CHINA BIOPHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1141US2024150460A1Anti-nkp30 antibody and application thereofSHENGHE CHINA BIOPHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1241US2025263499A1Anti-cd24 antibody and use thereofSHENGHE CHINA BIOPHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1340US2025043015A1Anti-tnfr2 single domain antibody, and preparation method therefor and application thereofSHENGHE CHINA BIOPHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1440US2025320303A1Anti-tnfr2 antibody and preparation method and application thereofSHENGHE CHINA BIOPHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xiaoling Jiang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →